Document Detail


[Osteoporosis in men].
MedLine Citation:
PMID:  20546723     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Osteoporosis in men continues to be underdiagnosed and undertreated. Its presence makes it necessary to rule out predisposing conditions and diseases. General prevention measures should be recommended and when necessary also supplementation with 1200mg/day of calcium and at least 800IU/day of vitamin D. Bisphosphonates, specifically alendronate (ALN) and risedronate (RSN), are the treatment of choice in men with osteoporosis. In severe cases with high risk of fracture and in patients with therapeutic failure with the bisphosphonates or who do not tolerate these drugs, the use of teriparatide may be recommended. The evidence available suggests that anti-fracture efficacy of treatment with ALN, RSN and teriparatide is similar in both genders. Androgens are only justified if there is clinical hypogonadism. Even in this case, bisphosphonates or teriparatide should probably be associated if the risk of fracture is very high in spite of androgen replacement.
Authors:
M J Moro-Alvarez; J A Blázquez Cabrera
Publication Detail:
Type:  Case Reports; English Abstract; Journal Article; Review     Date:  2010-05-23
Journal Detail:
Title:  Revista clínica española     Volume:  210     ISSN:  1578-1860     ISO Abbreviation:  Rev Clin Esp     Publication Date:    2010 Jul-Aug
Date Detail:
Created Date:  2010-07-08     Completed Date:  2010-11-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8608576     Medline TA:  Rev Clin Esp     Country:  Spain    
Other Details:
Languages:  spa     Pagination:  342-9     Citation Subset:  IM    
Affiliation:
Unidad de Metabolismo Mineral y Oseo, Servicio de Medicina Interna, Hospital Central de la Cruz Roja, Madrid, España.
Vernacular Title:
Osteoporosis en el varón.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Algorithms
Humans
Male
Osteoporosis* / diagnosis,  therapy
Practice Guidelines as Topic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The sigma agonist 1,3-di-o-tolylguanidine directly blocks SK channels in dopaminergic neurons and in...
Next Document:  On the pulmonary toxicity of oxygen: III. The induction of oxygen dependency by oxygen use.